Attached files
| file | filename |
|---|---|
| EX-10.4 - EX-10.4 - Quotient Ltd | d863853dex104.htm |
| EX-10.3 - EX-10.3 - Quotient Ltd | d863853dex103.htm |
| EX-10.2 - EX-10.2 - Quotient Ltd | d863853dex102.htm |
| EX-10.1 - EX-10.1 - Quotient Ltd | d863853dex101.htm |
| 8-K - FORM 8-K - Quotient Ltd | d863853d8k.htm |
Exhibit 10.5
|
Name Surname T +41 22 716 98 00 franz.walt@quotientbd.com |
7 January 2020
Private & Confidential
Jeremy Stackawitz
c/o Quotient
Dear Jeremy,
CONTRACT AMENDMENT – CHANGE TO ROLE
Further to recent discussions, I am pleased to confirm the following change to your role effective from 1 January 2020.
Change to Job Title
I can confirm that from 1 January 2020 your new job title will be Chief Commercial Officer.
All other terms and conditions of your contract of employment remain the same.
I would appreciate if you could sign both copies of this document, returning one copy to Human Resources and keeping the other for your records.
If you have any questions relating to this matter, please do not hesitate to contact me.
Yours sincerely,
/s/ Franz Walt
Franz Walt
Chief Executive Officer
Alba Bioscience Limited, Registered in Scotland No. SC310584
Allan-Robb Campus, 5 James Hamilton Way, Milton Bridge, Penicuik EH26 0BF
T +44 (0) 131 357 3333, quotientbd.com
I confirm my acceptance of these revised terms and conditions of employment.
| Signed | /s/ Jeremy Stackawitz | Date | January 7, 2020 | |||||
| Jeremy Stackawitz | ||||||||
Quotient Biocampus Limited, Registered in Scotland No. SC514165
Allan-Robb Campus, 5 James Hamilton Way, Milton Bridge, Penicuik EH26 0BF
T +44 (0) 131 357 3333, quotientbd.com